Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
issivyscius kognityvini funkcij sutrikimams ir neuropsichinms nepageidaujamoms reakcijoms, btina sumazinti zikonotido doz ar nutraukti gydym, taip pat reikia apsvarstyti kitas galimas sias bsenas sukeliancias priezastis.
the ziconotide dose should be reduced or discontinued if signs or symptoms of cognitive impairment or neuropsychiatric adverse reactions develop, but other contributing causes should also be considered.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
issivyscius kognityvini funkcij sutrikimams ir neuropsichinms nepageidaujamoms reakcijoms, btina sumazinti zikonotido doz ar nutraukti gydym, taip pat reikia apsvarstyti kitas galimas sias bsenas sukeliancias priezastis.kognityvins funkcijos paprastai
the ziconotide dose should be reduced or discontinued if signs or symptoms of cognitive impairment or neuropsychiatric adverse reactions develop, but other contributing causes should also be considered.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dl to, issivyscius khss, nepatartina skirti zcg ir turti lytinius santykius (arba rekomenduojama naudoti barjerines apsaugos priemones maziausiai keturias dienas) .
it is therefore prudent not to give hcg in cases where ohss is developing and not to have sexual intercourse or use barrier methods for at least four days.
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dl potencialiai pavojing klinikini odos ir kraujagysli isopjimo padarini, kuriuos patyr kaul ciulp proliferacijos ligomis sergantys pacientai, issivyscius odos ir kraujagysli opoms hidroksikarbamido vartojim reikia nutraukti ir (arba) sumazinti jo doz.
due to potentially severe clinical outcomes for the cutaneous vasculitic ulcers reported in patients with myeloproliferative disease, hydroxycarbamide should be discontinued and/or its dose reduced if cutaneous vasculitic ulcerations develop.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.